Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with
Matlooba A AlZadjali1, Valerie Godfrey, Faisel Khan
1University of Dundee, Ninewells Hospital and Medical School, United Kingdom.
Insights
Insulin resistance (IR) affects 61% of patients with chronic heart failure (CHF). This condition is linked to reduced exercise capacity and poorer health outcomes in individuals with CHF.
Area of Science:
- Cardiology
- Metabolic Disorders
Background:
- Chronic heart failure (CHF) is increasingly recognized as a state of insulin resistance (IR).
- The precise prevalence and clinical implications of IR in CHF remain incompletely defined.
Purpose of the Study:
- To determine the prevalence of insulin resistance (IR) in nondiabetic patients with chronic heart failure (CHF).
- To identify factors associated with IR in CHF.
- To examine the relationship between IR and functional class, exercise capacity, and disease severity in CHF patients.
Main Methods:
- Assessed insulin resistance using the fasting insulin resistance index (FIRI) in 129 consecutive CHF patients.
- Conducted cardiopulmonary exercise testing.
- Performed peripheral endothelial function testing using reactive hyperemia peripheral arterial tonometry (RH-PAT).
Main Results:
- Identified a high prevalence of IR (61%) in the CHF cohort, defined by FIRI ≥ 2.7.
- Found significant correlations between IR and waist circumference, triglycerides, HDL cholesterol, and leptin levels.
- Observed that IR was associated with worsening New York Heart Association functional class, reduced exercise capacity, and impaired endothelial function.
Conclusions:
- Insulin resistance is highly prevalent in nondiabetic patients with chronic heart failure.
- IR in CHF patients is associated with decreased exercise capacity and poorer functional status.
Objectives:
The purpose of this study was to establish the prevalence of insulin resistance (IR) among nondiabetic chronic heart failure (CHF) patients and to seek factors associated with IR in CHF, including the relationship of IR to functional class, exercise capacity, and disease severity in CHF.
Background:
Several lines of evidence suggest that CHF is an IR state. The prevalence of IR in CHF and its relation to CHF have not been fully defined.
Methods:
Fasting insulin resistance index (FIRI) was assessed in a cohort of 129 consecutive CHF patients (mean age 69.2 +/- 10.4 years; 76% males; body mass index 27.4 +/- 4.4 kg/m(2)). Patients underwent cardiopulmonary exercise testing and peripheral endothelial function testing by reactive hyperemia peripheral arterial tonometry (RH-PAT).
Results:
Prevalence of IR as defined by FIRI > or =2.7 was 61% in our cohort of CHF patients. There was a significant correlation between IR and waist circumference (r = 0.37; p < 0.01), serum triglycerides (r = 0.34; p < 0.01), high-density lipoprotein cholesterol (r = -0.22; p = 0.02), and serum leptin (r = 0.39; p = 0.03). Insulin resistance increased significantly with worsening New York Heart Association functional class (p < 0.01). The CHF patients with IR had a significantly lower exercise capacity and peak oxygen consumption than patients with an FIRI <2.7. The RH-PAT ratio was significantly lower in CHF patients with IR compared with CHF patients with an FIRI <2.7 (1.6 +/- 0.3 vs. 2.0 +/- 0.5; p < 0.05).
Conclusions:
Insulin resistance is highly prevalent among nondiabetic CHF patients and is associated with decreased exercise capacity in patients with CHF. (Insulin Resistance: Heart Failure; NCT00486967).
More Related Videos
06:13Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
Published on: December 1, 2023
07:49A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
Published on: July 21, 2023
Related Concept Videos
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure V: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Heart Failure II: Pathophysiology
